HelpAcademyLoginJoin us as a Member

Renalytix plc

Sign in to save Renalytix plc to a watchlist Sign in to set an alert for Renalytix plc
Tickers
RNLXY, RENXF
Headquarters
Not recorded
SEC CIK
0001811115
Website
Not recorded

Closing prices

Drugs

No drugs from this company are tracked yet.

FDA-approved applications

Catalysts

No catalysts yet. Editors add each date together with its source.

Deals

No approved deals involve this company yet.

Reported fundamentals (SEC XBRL)

SEC filings

SEC filings from Renalytix plc, newest first
FormFiledWhat it coversDocument
424B3 Form 424B3 View Form 424B3 filed 30 Jul 2025 on sec.gov (opens in a new tab)Filing index for 0001193805-25-001128 (opens in a new tab)
8-K Current report (8-K)
  • Regulation FD disclosure (Item 7.01)
View Current report (8-K) filed 16 Jan 2025 on sec.gov (opens in a new tab)Filing index for 0001213900-25-004220 (opens in a new tab)
8-KEvent 19 Dec 2024 Current report (8-K)
  • Shareholder vote results (Item 5.07)
  • Regulation FD disclosure (Item 7.01)
  • Financial statements and exhibits (Item 9.01)
View Current report (8-K) filed 20 Dec 2024 on sec.gov (opens in a new tab)Filing index for 0001213900-24-111219 (opens in a new tab)
DEF 14AEvent 19 Dec 2024 Proxy statement (DEF 14A) View Proxy statement (DEF 14A) filed 25 Nov 2024 on sec.gov (opens in a new tab)Filing index for 0001213900-24-102087 (opens in a new tab)
8-K/AEvent 26 Sep 2024 Amended current report (8-K/A)
  • Entry into a material definitive agreement (Item 1.01)
  • Creation of a direct financial obligation (Item 2.03)
  • Financial statements and exhibits (Item 9.01)
View Amended current report (8-K/A) filed 19 Nov 2024 on sec.gov (opens in a new tab)Filing index for 0001213900-24-100211 (opens in a new tab)
10-QEvent 30 Sep 2024 Quarterly report (10-Q) View Quarterly report (10-Q) filed 19 Nov 2024 on sec.gov (opens in a new tab)Filing index for 0000950170-24-128687 (opens in a new tab)
SC 13G/A Amended passive ownership report (13G/A) View Amended passive ownership report (13G/A) filed 14 Nov 2024 on sec.gov (opens in a new tab)Filing index for 0001104659-24-118635 (opens in a new tab)
SC 13D/A Form SC 13D/A View Form SC 13D/A filed 7 Nov 2024 on sec.gov (opens in a new tab)Filing index for 0001104659-24-115272 (opens in a new tab)
8-KEvent 31 Oct 2024 Current report (8-K)
  • Departure or appointment of directors or officers (Item 5.02)
  • Shareholder vote results (Item 5.07)
  • Regulation FD disclosure (Item 7.01)
  • Financial statements and exhibits (Item 9.01)
View Current report (8-K) filed 6 Nov 2024 on sec.gov (opens in a new tab)Filing index for 0001213900-24-095002 (opens in a new tab)
4Event 1 Nov 2024 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 5 Nov 2024 on sec.gov (opens in a new tab)Filing index for 0000950170-24-121609 (opens in a new tab)

Source: SEC EDGAR. Each row links to the filing on sec.gov.

Related news

No recent headlines mention this company.

Insider transactions

All rows for Renalytix plc on Insider Trades

Last 90 days of Form 4 filings, from 3 Aug 2026 (US Eastern dates).

Buys code P
None in this period
Sells code S
None in this period
Other all other codes
None in this period

Last transaction:

Insider filings are public records and are not a recommendation. Source: SEC EDGAR.

Sources

Nothing on this page is investment advice.